Using GLP-1 agonist medications during breastfeeding for pre-diabetes
As a breastfeeding mother with pre-diabetes, you're likely looking for ways to manage your condition while continuing to nourish your baby. One of the medications that has gained popularity for its effectiveness in managing pre-diabetes is the GLP-1 agonist. However, there's a lot of confusion around the safety of GLP-1 agonists during breastfeeding. In this article, we'll break down what we know about the use of GLP-1 agonists during breastfeeding for pre-diabetes.
What are GLP-1 agonists?
GLP-1 agonists, also known as glucagon-like peptide-1 agonists, are a class of medications that mimic the action of the natural hormone GLP-1. GLP-1 is produced in the intestines and helps to regulate blood sugar levels by stimulating insulin release and slowing gastric emptying. GLP-1 agonists, such as semaglutide and liraglutide, have been shown to be effective in managing type 2 diabetes and promoting weight loss.
How do GLP-1 agonists work?
GLP-1 agonists work by mimicking the action of GLP-1 in the body. They stimulate the release of insulin and slow gastric emptying, which helps to regulate blood sugar levels and promote weight loss. They also reduce hunger and increase feelings of fullness, making it easier to stick to a healthy diet.
